Integrated Biosciences is an early-stage biotechnology company combining synthetic biology and AI to control cellular stress responses for next-generation therapeutics. The company has pioneered the use of optogenetics, diverse small-molecule chemistry, and ultra-large AI models for drug discovery, identifying new classes of small molecules that are under development for addressing acute, age-related diseases. The company was founded in 2022 by Felix Wong, Ph.D., a leading biophysicist, and Max Wilson, Ph.D., a professor of biology.